Kiniksa Pharmaceuticals International, plc Other Non-Current Liabilities
Kiniksa Pharmaceuticals International, plc (KNSA) had Other Non-Current Liabilities of $25.32 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-04-28
- 2026-03-31: Other Liabilities, Noncurrent $25.32M.
- 2025-12-31: Other Liabilities, Noncurrent $18.52M.
- 2025-09-30: Other Liabilities, Noncurrent $14.53M.
- 2025-06-30: Other Liabilities, Noncurrent $9.26M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-03-31 | $25.32M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $18.52M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $14.53M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $9.26M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $5.14M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $1.82M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.96M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $1.93M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $1.89M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $1.86M 10-K · filed 2025-02-25 |
| 2023-09-30 | $1.95M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.92M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $1.88M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.84M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.82M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $260.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $271.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $270.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $885.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.14M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $809.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $805.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $957.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $334.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $381.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $326.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $943.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $943.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $509.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $144.00K 10-K · filed 2020-03-05 |